Antibiotic Resistance: What are the Opportunities for Primary Care in Alleviating the Crisis? by Malene Plejdrup Hansen et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PUBLIC HEALTH
REVIEWS IN MEDICINE
published: 24 February 2015
doi: 10.3389/fpubh.2015.00035
Antibiotic resistance: what are the opportunities for
primary care in alleviating the crisis?
Malene Plejdrup Hansen1,Tammy C. Hoffmann1, Amanda R. McCullough1, Mieke L. van Driel 2 and
Chris B. Del Mar 1*
1 Centre for Research in Evidence-Based Practice, Bond University, Gold Coast, QLD, Australia
2 Discipline of General Practice, School of Medicine, University of Queensland, Brisbane, QLD, Australia
Edited by:
Aline Ramond-Roquin, University of
Angers, France
Reviewed by:
Julie Dupouy, Université Paul
Sabatier, France
Olivier Saint-Lary, Université de
Versailles Saint-Quentin-en-Yvelines,
France
Yoann Gaboreau, Université Grenoble
Alpes, France
*Correspondence:
Chris B. Del Mar , Centre for Research
in Evidence-Based Practice, Bond
University, 14 University Drive Gold
Coast, QLD 4229, Australia
e-mail: cdelmar@bond.edu.au
Numerous opportunities are available in primary care for alleviating the crisis of increasing
antibiotic resistance. Preventing patients from developing an acute respiratory infection
(ARI) will obviate any need for antibiotic use downstream. Hygiene measures such as
physical barriers and hand hygiene, and possibly vaccination and exercise, may be effec-
tive. Also, a large range of complementary and alternative medicines (e.g. zinc, vitamin C
and probiotics) are proposed for preventing and treating ARIs, but evidence for efficacy is
scarce.
General practitioners’ (GPs) attitudes towards antibiotic prescribing are a major factor in the
prescribing for ARIs. Professional interventions with educational components are effective,
although they have modest effects, and are expensive. GPs’ perceptions – that mistakenly
assume as a default that patients want antibiotics for their ARIs – are often wrong. Shared
decision making might be a solution, as it enables clinician and patient to participate jointly
in making a health decision, having discussed the options together with the evidence for
their harms as well as benefits.
Furthermore, GPs’ diagnostic uncertainty – often leading to an antibiotic prescription “just
in case” – might be addressed by exploiting strategies such as safety-netting, e.g., estab-
lishing with the patient a priori clearly defined actions to take if the course of the illness
deviates from the expected.
None of these strategies or interventions on their own will greatly improve the use of antibi-
otics for ARIs. However, used in concert, combinations are likely to enable clinicians and
health care systems to implement the strategies that will reduce antimicrobial resistance
in the future.
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SETTING THE SCENE
In the past 70 years, antibiotics have been essential in the fight
against infectious diseases and have been a contributing factor in
the rise in life expectancy (1). However,we are now gradually facing
a post-antibiotic era, a time when antibiotics are no longer effec-
tive because bacteria have become more and more resistant. The
World Health Organisations’ 2014 report on global surveillance
of antimicrobial resistance reveals that antibiotic resistance is no
longer a prediction for the future; it is happening right now, across
the world, and is putting at risk the ability to treat common infec-
tions in both the community and hospitals (2). Excessive and inap-
propriate use of antibiotics is considered to be the most impor-
tant cause of the increasing problems with resistant bacteria (3).
Consequences are not only at a population level but also for indi-
vidual patients, as it is shown that individuals who are prescribed
an antibiotic for a respiratory or urinary infection can develop
bacterial resistance to that antibiotic for up to 12 months (4).
The majority of antibiotics are prescribed in primary care
(5) and mainly for acute respiratory infections (ARIs) (6). ARI
is an overall term for a group of illnesses and the most com-
mon infections presenting in primary care are acute otitis media,
acute sinusitis, acute tonsillitis, acute pharyngitis, acute bronchi-
tis, pneumonia, the common cold, and influenza. These infections
are very common in the community and more than 50% of the
adult population experience ARI symptoms during a 6-month
period and one-fifth of them will consult a general practitioner
(GP) (7). As much as 90% of patients diagnosed with acute otitis
media, acute sinusitis, or acute tonsillitis are treated with antibi-
otics in some countries (8, 9). In US, the antibiotic prescribing
rate for acute bronchitis is about 70% (10), and in Australia
(for GP registrars) about 73% (11), despite evidence suggest-
ing that the antibiotic prescribing rate for this should be near
0 (12).
The solution seems at first to be straightforward: targeting the
use of antibiotics in the community – which is where the greatest
tonnage is prescribed and the efficacy of their use is most limited
(12–15). Within about a year, over 90% of commensal antibi-
otic resistance dissipates (4). Despite the existence of guidelines,
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which recommend appropriate prescribing of antibiotics in the
community, antibiotics are still prescribed for ARIs much more
than guidelines recommend (16, 17). The cause of this cogni-
tive dissonance is almost certainly more than simply a matter of
prescriber personal habit (18) and requires an understanding of
the various reasons, which can drive clinicians to over-prescribe
antibiotics for ARIs. The aim of this paper is to provide an overview
of the opportunities and strategies for reducing antibiotic use
for ARIs in primary care and outline potential areas for future
research.
STRATEGIES
Understanding the events of decision points surrounding an
antibiotic prescription for ARIs in primary care can inform strate-
gies to address the problem at each of these points. This paper
considers the path from a healthy person, to a person with symp-
toms of ARIs, to a person consulting a GP, who may or may not be
prescribed an antibiotic (Figure 1). The author team discussed and
came to consensus on strategies that were likely to be used at each
stage of this pathway. We then used keywords and subject headings
for each strategy to search CENTRAL and PubMed (up to October
2014) to identify the highest level of evidence available for each
strategy, according to conventional hierarchy of evidence (19).
HEALTHY PEOPLE
Of course, prevention of ARIs in the first place will reduce the
whole downstream use of antibiotics.
VACCINATION
Haemophilus influenzae type b (Hib) is an important cause of
pneumonia and meningitis in children, and the Hib vaccine is safe
and effective in reducing Hib disease (20). Pneumococcal polysac-
charide vaccines are effective in preventing the rarer outcome of
invasive pneumococcal disease, but evidence from meta-analysis
does not support the routine use of pneumococcal polysaccha-
ride vaccines to prevent all-cause pneumonia or mortality (21).
Vaccination is also often proposed for prevention of influenza.
In healthy adults, it has been demonstrated to decrease the risk
of symptoms of influenza and time off work, but it does not
reduce complications or transmission in healthy adults (22). The
etiological organisms for ARIs are numerous and the current vac-
cination options are unlikely to be able to influence more than a
tiny proportion of infections.
FIGURE 1 | Overview of strategies to minimize antibiotic use in primary care at each stage of the path from healthy person to antibiotic prescription
for acute respiratory infection.
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EXERCISE
Exercise might also reduce the incidence of ARIs, as well as their
duration and severity (23).
However, these results need confirmation in other studies
before exercise can be recommended for preventing ARIs, a
Cochrane review is currently addressing this question (24).
COMPLEMENTARY AND ALTERNATIVE MEDICINE
Probiotics, Echinacea, and vitamin C are sometimes suggested for
preventing ARIs. Vitamin C has been used for more than 80 years,
although a Cochrane review concludes that it does not reduce the
incidence of common cold (25). Another Cochrane review found
that trials investigating Echinacea for preventing common cold did
not show statistically significant reductions in illness occurrence.
However, nearly all prevention trials pointed in the direction of
small preventive effects (26). Importantly, the available Echinacea
products differ greatly in content of active components and due
to significant differences in the preparations tested, it is not pos-
sible to draw strong conclusions about the effect of Echinacea in
either preventing or treating common colds (26). Probiotics (live
microorganisms) are also proposed for preventing ARIs and are
found to be marginally better than placebo in terms of the num-
ber of participants who experience at least one episode of an acute
upper respiratory tract infection [odds ratio (OR) 0.58; 95% con-
fidence interval (CI) 0.36–0.92] (27). Further trials are needed to
strengthen the evidence about the potential for probiotics.
HYGIENE AND PHYSICAL BARRIERS
One way to diminish the number of people with ARIs is through
reducing the person-to-person transmission of pathogens by
applying physical barriers, hand hygiene, and so on. Respiratory
virus spread can be reduced by handwashing, especially around
younger children (28). It remains unclear if adding virucidals or
antiseptics to normal handwashing with soap is more effective
than regular soap (28). There are only limited data on the use of
masks and respirators in the community to reduce transmission of
virus, but their effectiveness is possibly linked to early, consistent,
and correct usage (29).
PEOPLE WITH SYMPTOMS OF AN ACUTE RESPIRATORY
INFECTION
NEED FOR REASSURANCE AND EXPECTATIONS OF ANTIBIOTICS
Patients with ARIs are mostly seeking information and reassurance
from their GP (30, 31). However, many patients overestimate the
effectiveness of antibiotics: approximately one-third of patients
believe that antibiotics are effective against cold and “flu” (32), and
nearly two-thirds believe that acute bronchitis requires antibiotic
treatment (33). The important corollary is that those who expect
an antibiotic for their ARI are nearly twice as likely to consult
their GP when affected by one (7). Pharmacists or other health
care providers, coming into contact with patients prior to GP con-
sultation, may be able to change patients’ beliefs about the need
for antibiotics for ARI by providing advice about self-care and
information about the expected duration of the illness (7).
Public campaigns may also have a role to play in address-
ing public misconceptions about the effectiveness of antibiotics.
There have been numerous campaigns in high-income countries
to promote appropriate antibiotic use, which vary from simple,
low-cost internet campaigns to expensive mass-media campaigns.
Although evidence for a cause–effect relation is lacking and the
effects are variable, the results of several campaigns suggest that
they can decrease the inappropriate use of antibiotics. As an exam-
ple, in France and Belgium, antibiotic use declined by as much as
27 and 36%, respectively (34).
SYMPTOM RELIEF
Antibiotics are seldom necessary for treatment of ARIs as most of
them are self-limiting conditions often caused by a virus. However,
patients with ARIs feel unwell and consequently seek symptom
relief (7, 31). Several symptomatic drugs as well as complemen-
tary and alternative treatments have been proposed. It is known
that drugs used for symptomatic treatment of ARIs increases as
antibiotic use decreases (35) and it is reasonable to assume that
effective symptomatic treatment would reduce pressure on the
decision to use antibiotics. Over-the-counter medicine like parac-
etamol (acetaminophen) and non-steroidal anti-inflammatory
drugs (NSAIDs) are commonly used for symptom relief. Parac-
etamol may help relieve nasal obstruction and rhinorrhea in
patients with common cold, but does not appear to improve
other cold symptoms like sore throat, malaise, or cough (36).
Another Cochrane review found that NSAIDs may improve many
analgesia-related symptoms like headache, ear pain, and muscle
and joint pain caused by the common cold (37). However, the
results of the studies included in the review are diverse and the
number of studies for one result is very small.
Steroids are also used for relieving symptoms, especially of
acute rhinosinusitis. Intranasal corticosteroids have been found
to have a modest effect in the resolution or improvement of symp-
toms of acute sinusitis [risk ratio (RR) 1.11; 95% CI 1.04–1.18] in
a Cochrane review (38). Another review have demonstrated that
oral corticosteroids as a monotherapy appear to be ineffective for
treatment of adult patients with clinically diagnosed acute sinusitis
(39), but in combination with antibiotics it may be modestly bene-
ficial for short-term relief of symptoms in acute sinusitis [number
needed to treat (NNT)= 7 for resolution or symptom improve-
ment] (39). However, the evidence is limited, as almost all trials
included in the review are performed in secondary care and there
is a significant risk of bias. A large primary care trial is needed
to establish whether oral corticosteroids offer additional benefits
over antibiotics in clinically diagnosed acute sinusitis.
A large range of complementary and alternative medicine is
available for symptomatic treatment of ARIs. Vitamin C has been
proposed for treating respiratory tract infections and weak evi-
dence suggests regular supplementation of vitamin C might be
effective in reducing the duration of common cold by 8% (4–
12%) in adults and 14% (7–21%) in children (25). Echinacea is
also commonly used for the treatment of ARIs, although Echinacea
products have not been shown to provide benefits for treating com-
mon colds (26). Probiotics have no effect on the mean duration
(MD) of an episode of acute upper respiratory tract infection (MD
−0.29; 95% CI−3.71 to 3.13), but their use reduces the antibiotic
prescription rate (OR 0.67; 95% CI 0.45–0.98) (27).
Zinc inhibits replication of virus and has been tested in tri-
als for the treatment of the common cold. A Cochrane review
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demonstrated that when zinc is administered within 24 h of onset
of symptoms, it reduces the duration (days) of common cold
symptoms in healthy people (mean difference of −1.03 days; 95%
CI−1.72 to−0.34) (40). However, due to heterogeneity of the data
results from the review should be interpreted with caution. Heated,
humidified air has long been used by people with a common cold,
on a theoretical basis that steam may help congested mucus drain
better and heat may destroy the cold virus. A Cochrane review
of six trials found that steam inhalation provided no consistent
benefit in the treatment of the common cold. Three trials found
benefits of steam for symptom relief with the common cold (OR
0.31; 95% CI 0.16–0.60). The sample size, however, was small and
studies showed significant heterogeneity (41).
Caffeine as an analgesic adjuvant has been discussed for many
years. In a Cochrane review based on 19 studies with a total of 7238
patients with different pain conditions, caffeine enhanced the effi-
cacy of paracetamol, ibuprofen, or aspirin with a NNT of about
15 (42). However, only one trial related to ARIs were included in
this review (43, 44).
Although the body of existing evidence is limited, it suggests
that there is minimal benefit for the use of these non-antibiotic
alternatives and larger, high quality, primary care-based studies are
needed to further explore these alternatives and to develop and test
new non-antibiotic treatments for ARIs.
PATIENT CONSULTING A GENERAL PRACTITIONER
GP PRESCRIBING HABITS
There are wide variations in GPs’ antibiotic prescribing rates (45,
46) and GPs’ attitudes are a major influencing factor (18). GP
education is a common component of most trials designed to
address this issue (47, 48). One approach focuses on better com-
munication skills: GPs who receive specific communication skills
training prescribe fewer antibiotics for patients with ARIs [27%
compared with 54% in the no training group (P < 0.01)] (49),
even at long-term follow-up (50). A significant long-term effect
has also been demonstrated on the prescribing behavior of GPs
after participating in a medical educational program (between-
group difference after 30-month 1.99%, 95% CI 0.56–3.42) (35).
However, the effect of these comprehensive interventions seems
quite modest when estimating the precise number of antibiotic
prescriptions saved. The number of antibiotic prescriptions for
lower respiratory tract infections was reduced from 2 prescrip-
tions/week/GP to 1 prescription/week/GP in the study by Cals
et al. (49) and a reduction in total antibiotic prescriptions from 11
prescriptions/week/GP to 8.5 prescriptions/week/GP was demon-
strated in the French study (35). Although it seems very difficult to
change GPs’ behavior, a simple intervention was recently carried
out in US. This was a behavioral “nudge” in the format of a pub-
lic commitment device – a poster-sized letter signed by clinicians
and posted in the examination room. The intervention resulted in
a 20% absolute reduction in inappropriate antibiotic prescribing
for ARIs (51).
PERCEIVED PATIENT DEMAND AND PATIENT EXPECTATIONS
General practitioners often feel patients with ARIs are consulting
with an expectation of antibiotics (52, 53). Back in 1998, Butler
et al. found that: “Doctors knew of the evidence for marginal
effectiveness, yet often prescribed for good relationships with
patients” (54). This paradox is still current and may be one of the
main contributors to the ongoing over-prescribing of antibiotics
for ARIs. However, GPs often mistakenly assume their patients’
expectations (55). Patient satisfaction is associated with reassur-
ance and information and not just with an antibiotic prescription
(30, 31). Shared decision making may have an important role
to play in addressing patient expectations and concerns. In the
shared decision making process, evidence is brought into the dis-
cussion with patients, and their concerns and expectations are
explicitly sought (56). The process enables clinician and patient to
participate jointly in making a health decision, having discussed
the options and their benefits and harms, and having considered
the patient’s values, preferences, and circumstances (57). As the
benefit-harm balance of antibiotics is very finely balanced, com-
municating this to patients may reduce their desire for antibiotics.
Shared decision making has been shown to reduce antibiotic pre-
scribing for ARIs in a number of trials (58–60), and a Cochrane
review of this is currently underway (61).
DIAGNOSTIC UNCERTAINTY
The relationship between diagnostic uncertainty and antibiotic
misuse has been demonstrated in several studies (18). Clinicians
typically only have a few minutes to decide if the patient has a
serious infection, or is at risk of complications. The point-of-care
test, C-reactive protein (CRP), has been proposed as a solution to
this clinical dilemma. It is widely used in some European primary
care settings (62, 63), while in other countries it is barely used (64).
CRP-testing has been shown to significantly reduce antibiotic pre-
scribing for patients with ARIs (RR 0.75, 95% CI= 0.67–0.83) (65)
and it might be a useful strategy to increase patient satisfaction
without compromising patient recovery (49).
In nearly 30 years, the rapid antigen detection test has been
used for detection of Lancefield group A β-hemolytic streptococci
(GABHS) in patients with a sore throat. Not all patients with a
positive test and throat symptoms have an infection caused by
GABHS (66, 67), and they may not benefit from antibiotic treat-
ment. Still its use has been shown to significantly reduce antibiotic
prescription for sore throat by more than 20% (68, 69). However,
compared with the use of a clinical score alone to guide antibiotic
prescribing, there is no effect of additional use of rapid antigen
detection test in patients with a sore throat either for symptom
management or for antibiotic use (69).
Procalcitonin is a promising biomarker for identification of
bacterial infections. So far, meta-analyses have mainly investigated
the use of procalcitonin as a diagnostic marker for sepsis (70, 71),
but a Cochrane review from 2012 concluded that procalcitonin is
a safe and effective tool to guide clinical decisions for antibiotic
initiation and duration of treatment in patients with ARIs (72).
However, evidence for the use of procalcitonin in primary care
for ARIs is still limited and further trials are needed to assess the
diagnostic accuracy of this biomarker in primary care.
General practitioners may prescribe antibiotics to prevent com-
plications like quinsy, mastoiditis, and pneumonia, although the
rates of serious complications are low in modern developed coun-
tries (73, 74). History, examination, and scores to predict bac-
terial infection cannot usefully identify those who will develop
Frontiers in Public Health | Family Medicine and Primary Care February 2015 | Volume 3 | Article 35 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hansen et al. Alleviating the antibiotic resistance crisis
complications (75). GPs will need to rely on strategies such as
“safety-netting” in managing the diagnostic uncertainty. The con-
cept of“safety-netting”– that is, establishing clearly defined actions
to take if the course of the illness deviates from the expected –
was introduced in a book about primary care consulting in 1990s
(76). Evaluation of this strategy and its effects on patient care is
needed (77). Delayed prescribing is actually one form of safety-
netting and is an effective strategy to deal with the diagnostic
uncertainty. A Cochrane review demonstrated that delayed pre-
scribing resulted in 32% of patients using antibiotics compared to
93% of patients in the immediate prescription group (78). Some
of the included studies in the review found that in patients with
acute otitis media and sore throat prescribing immediate antibi-
otics was more effective than delayed prescribing for fever, pain,
and malaise (78). However, a newly published randomized con-
trolled trial showed little difference in symptom control between
strategies involving no prescription, immediate prescription, or
delayed prescription (79).
TIME PRESSURE
Busy GPs are more liberal with antibiotics for ARIs than less
busy GPs, and use a greater proportion of broad-spectrum antibi-
otics (80). Unfortunately, GPs often have limited time for con-
sultations dealing with patients with acute illness such as ARIs.
In many countries, GPs are, among other things, increasingly
required to take care of patients with chronic diseases. How-
ever, consultations for acute illness should also be prioritized as
the pressure of limited time in primary care is correlated with
antibiotic prescribing (18). Moreover, the cycle is perpetuating as
patients who have been previously prescribed antibiotics for ARIs
are more likely to re-consult their GP rather than self-manage
for subsequent infections (81). This suggests that investing just
a few minutes in shared decision making might be effective at
reducing antibiotic prescribing (58) – as well as reducing future
visits.
THERAPEUTIC VACUUM
How can GPs manage the therapeutic vacuums left by not pre-
scribing antibiotics? Over-the-counter drugs, complementary and
alternative medicines, or steroids might be recommended for
patients with some ARIs. Others might benefit from advice on
preventing future ARIs by routine handwashing. Most patients
are satisfied with a good explanation of their symptoms (30), and
information of the minimal benefits of antibiotics for ARIs to
understand the benefit-harm trade-off.
MISMATCH BETWEEN GUIDELINES AND PACKET SIZE
Often patients end up with leftover antibiotics because there is a
mismatch between guidelines and the packet size of antibiotics.
This is a problem because leftovers are saved and used for self-
medication (82). Antibiotics that have been prescribed for one dis-
ease are subsequently used as self-medication for repeated episodes
of the same disease, and also for other symptoms that are not nec-
essarily caused by a bacterial illness (83). Redundant antibiotics are
a potentially remediable source of antibiotic overuse and national
regulatory authorities should ensure that the recommended dose
of an antibiotic match the packet prescribed.
CONCLUSION
There are numerous opportunities available in primary care for
alleviating the crisis of increasing antibiotic resistance. None of
these strategies or interventions on their own will greatly improve
the use of antibiotics for ARIs. However, used in concert, combi-
nations are likely to enable clinicians and health care systems to
implement the strategies that will reduce antimicrobial resistance
in the future.
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